CD274 and hepatocellular carcinoma: Based on our previous experimental results demonstrating that BBR treatment reduces M2 polarization of macrophages while increasing T lymphocyte infiltration in the TIME, and considering the limited efficacy of PD-L1 inhibitor monotherapy in HCC (Zhang et al., 2025), BBR may complement anti-PD-L1 antibody-mediated ICI blockade.